Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
Leukemia & Lymphoma|October 1, 1993
Flow cytometric assessment of multidrug resistance (MDR) phenotype in acute myeloid leukaemiaS M Hart, K Ganeshaguru, M P Lyttelton, et al.British Journal of Haematology|September 1, 1981
Studies on the biochemical sequelae of therapy in Thy-acute lymphoblastic leukaemia with the adenosine deaminase inhibitor 2' deoxycoformycinN H Russell, H G Prentice, N Lee, et al.British Journal of Haematology|January 1, 1981
Immunofluorescent and biochemical studies of terminal deoxynucleotidyl transferase in treated acute leukaemiaK F Bradstock, G Janossy, A V Hoffbrand, et al.British Journal of Haematology|January 1, 1984
Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminaseN Lee, N Russell, K Ganeshaguru, et al.Blood|April 1, 1991
Stages of T-cell receptor protein expression in T-cell acute lymphoblastic leukemiaD Campana, J J van Dongen, A Mehta, et al.British Journal of Haematology|March 1, 1993
Alpha interferon in the treatment of chronic hepatitis C infection in thalassaemia majorS M Donohue, B Wonke, A V Hoffbrand, et al.British Journal of Haematology|February 1, 1992
Increase in 2',5'-oligoadenylate synthetase caused by deoxycoformycin in hairy cell leukaemiaK Ganeshaguru, W C de Mel, G Sissolak, et al.Lancet (London, England)|December 5, 1981
Therapeutic selectivity of and predication of response to 2'-deoxycoformycin in acute leukaemiaH G Prentice, N H Russell, N Lee, et al.Tropical and Geographical Medicine|July 1, 1987
Prevalence of thalassaemias in ethnic Saudi ArabiansK Ganeshaguru, J K Acquaye, A P Samuel, et al.Lancet (London, England)|July 26, 1980
Remission induction with adenosine-deaminase inhibitor 2'-deoxycoformycin in Thy-lymphoblastic leukaemiaH G Prentice, J F Smyth, K Ganeshaguru, et al.Pageof 6